{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T20:48:08Z","timestamp":1776977288674,"version":"3.51.4"},"reference-count":56,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T00:00:00Z","timestamp":1741737600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PID2022-139786OB-I00"],"award-info":[{"award-number":["PID2022-139786OB-I00"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["AESPI21\/01406"],"award-info":[{"award-number":["AESPI21\/01406"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["AESIPI21CIII\/00002"],"award-info":[{"award-number":["AESIPI21CIII\/00002"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["AESIPI22CIII\/00062"],"award-info":[{"award-number":["AESIPI22CIII\/00062"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CD22CIII\/00001"],"award-info":[{"award-number":["CD22CIII\/00001"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012818","name":"Comunidad de Madrid","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.neurot.2025.e00576","type":"journal-article","created":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T20:54:52Z","timestamp":1743454492000},"page":"e00576","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["VP3.15, a dual GSK-3\u03b2\/PDE7 inhibitor, reduces glioblastoma tumor growth though changes in the tumor microenvironment in a PTEN wild-type context"],"prefix":"10.1016","volume":"22","author":[{"given":"Maria","family":"Castello-Pons","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria A.","family":"Ramirez-Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Iglesias-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nermina Logo","family":"Lendo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Rodriguez-Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Quiralte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan-Manuel","family":"Sep\u00falveda-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olaya","family":"de Dios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Gil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pilar","family":"S\u00e1nchez-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Casas-Tinto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurot.2025.e00576_bib1","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 world Health organization classification of tumors of the central nervous system: a summary","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neurot.2025.e00576_bib2","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.3390\/cancers12061622","article-title":"Cellular plasticity and tumor microenvironment in gliomas: the struggle to hit a moving target","volume":"12","author":"Gargini","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.neurot.2025.e00576_bib3","doi-asserted-by":"crossref","DOI":"10.1172\/JCI163451","article-title":"Monocyte-neutrophil entanglement in glioblastoma","volume":"133","author":"Friedmann-Morvinski","year":"2023","journal-title":"J Clin Invest"},{"key":"10.1016\/j.neurot.2025.e00576_bib4","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s13311-016-0510-y","article-title":"New directions in anti-angiogenic therapy for glioblastoma","volume":"14","author":"Wang","year":"2017","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neurot.2025.e00576_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0107397","article-title":"PDE7B is a novel, prognostically significant mediator of glioblastoma growth whose expression is regulated by endothelial cells","volume":"9","author":"Brooks","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.neurot.2025.e00576_bib6","doi-asserted-by":"crossref","first-page":"31901","DOI":"10.18632\/oncotarget.5043","article-title":"GSK-3\u03b2 regulates tumor growth and angiogenesis in human glioma cells","volume":"6","author":"Zhao","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.neurot.2025.e00576_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.113823","article-title":"Elevated intracellular cAMP concentration mediates growth suppression in glioma cells","volume":"174","author":"Safitri","year":"2020","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.neurot.2025.e00576_bib8","doi-asserted-by":"crossref","first-page":"9665","DOI":"10.3390\/ijms22189665","article-title":"Suppression of proliferation of human glioblastoma cells by combined phosphodiesterase and multidrug resistance-associated protein 1 inhibition","volume":"22","author":"Kopanitsa","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.neurot.2025.e00576_bib9","doi-asserted-by":"crossref","first-page":"6643","DOI":"10.1158\/0008-5472.CAN-08-0850","article-title":"Glycogen synthase kinase-3 inhibition induces glioma cell death through c-MYC, nuclear factor-kappaB, and glucose regulation","volume":"68","author":"Kotliarova","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.neurot.2025.e00576_bib10","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1215\/15228517-2008-041","article-title":"Lithium inhibits invasion of glioma cells; possible involvement of glycogen synthase kinase-3","volume":"10","author":"Nowicki","year":"2008","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.neurot.2025.e00576_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013879","article-title":"Inhibition of glioblastoma growth by the thiadiazolidinone compound TDZD-8","volume":"5","author":"Aguilar-Morante","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.neurot.2025.e00576_bib12","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1093\/carcin\/bgt182","article-title":"Glycogen synthase kinase 3\u03b2 inhibition sensitizes human glioblastoma cells to temozolomide by affecting O6-methylguanine DNA methyltransferase promoter methylation via c-Myc signaling","volume":"34","author":"Pyko","year":"2013","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.neurot.2025.e00576_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017240","article-title":"Phosphodiesterase 7 inhibition preserves dopaminergic neurons in cellular and rodent models of Parkinson disease","volume":"6","author":"Morales-Garcia","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.neurot.2025.e00576_bib14","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1021\/jm201463v","article-title":"5-imino-1,2,4-thiadiazoles: first small molecules as substrate competitive inhibitors of glycogen synthase kinase 3","volume":"55","author":"Palomo","year":"2012","journal-title":"J Med Chem"},{"key":"10.1016\/j.neurot.2025.e00576_bib15","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1111\/bph.13192","article-title":"PDE7 inhibitor TC3.6 ameliorates symptomatology in a model of primary progressive multiple sclerosis","volume":"172","author":"Mestre","year":"2015","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.neurot.2025.e00576_bib16","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1021\/cn300105c","article-title":"Identification in silico and experimental validation of novel phosphodiesterase 7 inhibitors with efficacy in experimental autoimmune encephalomyelitis mice","volume":"3","author":"Redondo","year":"2012","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.neurot.2025.e00576_bib17","doi-asserted-by":"crossref","DOI":"10.1098\/rsos.170039","article-title":"Drosophila enhancer-Gal4 lines show ectopic expression during development","volume":"4","author":"Casas-Tint\u00f3","year":"2017","journal-title":"R Soc Open Sci"},{"key":"10.1016\/j.neurot.2025.e00576_bib18","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1242\/dev.118.2.401","article-title":"Targeted gene expression as a means of altering cell fates and generating dominant phenotypes","volume":"118","author":"Brand","year":"1993","journal-title":"Development"},{"key":"10.1016\/j.neurot.2025.e00576_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1000374","article-title":"A drosophila model for EGFR-Ras and PI3K-dependent human glioma","volume":"5","author":"Read","year":"2009","journal-title":"PLoS Genet"},{"key":"10.1016\/j.neurot.2025.e00576_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3000545","article-title":"Glioblastoma cells vampirize WNT from neurons and trigger a JNK\/MMP signaling loop that enhances glioblastoma progression and neurodegeneration","volume":"17","author":"Portela","year":"2019","journal-title":"PLoS Biol"},{"key":"10.1016\/j.neurot.2025.e00576_bib21","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/glia.23551","article-title":"Oncogenic dependence of glioma cells on kish\/TMEM167A regulation of vesicular trafficking","volume":"67","author":"Portela","year":"2019","journal-title":"Glia"},{"key":"10.1016\/j.neurot.2025.e00576_bib22","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1158\/0008-5472.CAN-20-3558","article-title":"Tumor-derived pericytes driven by EGFR mutations govern the vascular and immune microenvironment of gliomas","volume":"81","author":"Segura-Collar","year":"2021","journal-title":"Cancer Res"},{"key":"10.1016\/j.neurot.2025.e00576_bib23","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1016\/j.cell.2021.03.023","article-title":"Glioblastomas acquire myeloid-affiliated transcriptional programs via epigenetic immunoediting to elicit immune evasion","volume":"184","author":"Gangoso","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.neurot.2025.e00576_bib24","doi-asserted-by":"crossref","first-page":"7011","DOI":"10.1158\/0008-5472.CAN-04-1364","article-title":"Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma","volume":"64","author":"Galli","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.neurot.2025.e00576_bib25","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009210","article-title":"NKG2C\/KLRC2 tumor cell expression enhances immunotherapeutic efficacy against glioblastoma","volume":"12","author":"de Dios","year":"2024","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.neurot.2025.e00576_bib26","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/s41586-021-04369-3","article-title":"A human brain vascular atlas reveals diverse mediators of Alzheimer's risk","volume":"603","author":"Yang","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.neurot.2025.e00576_bib27","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/s41467-022-28372-y","article-title":"Single-cell analysis of human glioma and immune cells identifies S100A4 as an immunotherapy target","volume":"13","author":"Abdelfattah","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.neurot.2025.e00576_bib57","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","article-title":"Fast, sensitive and accurate integration of single-cell data with Harmony","volume":"16","author":"Korsunsky","year":"2019","journal-title":"Nat Methods"},{"key":"10.1016\/j.neurot.2025.e00576_bib58","first-page":"100882","article-title":"scCATCH: automatic annotation on cell types of clusters from single-cell RNA sequencing data","volume":"23","author":"Shao","year":"2020","journal-title":"i Sci"},{"key":"10.1016\/j.neurot.2025.e00576_bib28","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abl5165","article-title":"Interrogating glioma-M2 macrophage interactions identifies Gal-9\/Tim-3 as a viable target against PTEN-null glioblastoma","volume":"8","author":"Ni","year":"2022","journal-title":"Sci Adv"},{"key":"10.1016\/j.neurot.2025.e00576_bib29","article-title":"The M2 macrophage marker CD206: a novel prognostic indicator for acute myeloid leukemia","volume":"9","author":"Xu","year":"2019","journal-title":"OncoImmunology"},{"key":"10.1016\/j.neurot.2025.e00576_bib30","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1021\/jm201463v","article-title":"5-imino-1,2,4-thiadiazoles: first small molecules as substrate competitive inhibitors of glycogen synthase kinase 3","volume":"55","author":"Palomo","year":"2012","journal-title":"J Med Chem"},{"key":"10.1016\/j.neurot.2025.e00576_bib31","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1080\/14756366.2016.1265522","article-title":"Small molecules targeting glycogen synthase kinase 3 as potential drug candidates for the treatment of retinitis pigmentosa","volume":"32","author":"Marchena","year":"2017","journal-title":"J Enzym Inhib Med Chem"},{"key":"10.1016\/j.neurot.2025.e00576_bib32","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13024-018-0251-y","article-title":"Modulation of GSK-3 provides cellular and functional neuroprotection in the rd10 mouse model of retinitis pigmentosa","volume":"13","author":"S\u00e1nchez-Cruz","year":"2018","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.neurot.2025.e00576_bib33","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jchemneu.2016.12.001","article-title":"A preliminary investigation of phoshodiesterase 7 inhibitor VP3.15 as therapeutic agent for the treatment of experimental autoimmune encephalomyelitis mice","volume":"80","author":"Mart\u00edn-\u00c1lvarez","year":"2017","journal-title":"J Chem Neuroanat"},{"key":"10.1016\/j.neurot.2025.e00576_bib34","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.3390\/ijms22052440","article-title":"Dynamics of central remyelination and treatment evolution in a model of multiple sclerosis with optic coherence tomography","volume":"22","author":"Ben\u00edtez-Fern\u00e1ndez","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.neurot.2025.e00576_bib35","doi-asserted-by":"crossref","first-page":"6643","DOI":"10.1158\/0008-5472.CAN-08-0850","article-title":"Glycogen synthase kinase-3 inhibition induces glioma cell death through c-MYC, nuclear factor-kappaB, and glucose regulation","volume":"68","author":"Kotliarova","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.neurot.2025.e00576_bib36","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1215\/15228517-2008-041","article-title":"Lithium inhibits invasion of glioma cells; possible involvement of glycogen synthase kinase-3","volume":"10","author":"Nowicki","year":"2008","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.neurot.2025.e00576_bib37","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1158\/1078-0432.CCR-08-0760","article-title":"Potential therapeutic effect of glycogen synthase kinase 3beta inhibition against human glioblastoma","volume":"15","author":"Miyashita","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.neurot.2025.e00576_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0007443","article-title":"GSK3beta regulates differentiation and growth arrest in glioblastoma","volume":"4","author":"Korur","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.neurot.2025.e00576_bib39","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/ijc.25020","article-title":"Glycogen synthase kinases-3beta controls differentiation of malignant glioma cells","volume":"127","author":"Li","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1016\/j.neurot.2025.e00576_bib40","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.bbrc.2005.07.041","article-title":"Deregulated GSK3beta activity in colorectal cancer: its association with tumor cell survival and proliferation","volume":"334","author":"Shakoori","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.neurot.2025.e00576_bib41","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1021\/cn400166d","article-title":"Crosstalk between phosphodiesterase 7 and glycogen synthase kinase-3: two relevant therapeutic targets for neurological disorders","volume":"5","author":"Morales-Garcia","year":"2014","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.neurot.2025.e00576_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232214378","article-title":"The dual PDE7-GSK3\u03b2 inhibitor, VP3.15, as neuroprotective disease-modifying treatment in a model of primary progressive multiple sclerosis","volume":"23","author":"Ben\u00edtez-Fern\u00e1ndez","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.neurot.2025.e00576_bib43","doi-asserted-by":"crossref","DOI":"10.1038\/srep43545","article-title":"Promoting in vivo remyelination with small molecules: a neuroreparative pharmacological treatment for Multiple Sclerosis","volume":"7","author":"Medina-Rodr\u00edguez","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.neurot.2025.e00576_bib44","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.yexcr.2019.02.007","article-title":"Lipopolysaccharide mediates time-dependent macrophage M1\/M2 polarization through the Tim-3\/Galectin-9 signalling pathway","volume":"376","author":"Zhang","year":"2019","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.neurot.2025.e00576_bib45","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.bbrc.2015.09.100","article-title":"LOX-1 in macrophage migration in response to ox-LDL and the involvement of calpains","volume":"467","author":"Wang","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.neurot.2025.e00576_bib46","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.3390\/biom10081093","article-title":"Lysyl Oxidase (LOX): functional contributions to signaling pathways","volume":"10","author":"Laczko","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.neurot.2025.e00576_bib47","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH815>3.0.CO;2-N","article-title":"The Hedgehog signalling pathway and cancer","volume":"193","author":"Saldanha","year":"2001","journal-title":"J Pathol"},{"key":"10.1016\/j.neurot.2025.e00576_bib48","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1158\/0008-5472.CAN-10-1282","article-title":"Novel synthetic antagonists of canonical Wnt signaling inhibit colorectal cancer cell growth","volume":"71","author":"Waaler","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.neurot.2025.e00576_bib49","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.ccell.2018.07.009","article-title":"Notch signaling in the tumor microenvironment","volume":"34","author":"Meurette","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.neurot.2025.e00576_bib50","doi-asserted-by":"crossref","first-page":"34399","DOI":"10.1074\/jbc.M003997200","article-title":"Complex formation of adenomatous polyposis coli gene product and axin facilitates glycogen synthase kinase-3 beta-dependent phosphorylation of beta-catenin and down-regulates beta-catenin","volume":"275","author":"Hinoi","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neurot.2025.e00576_bib51","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1038\/sj.bjc.6601265","article-title":"Wnt-signalling pathway in ovarian epithelial tumours: increased expression of beta-catenin and GSK3beta","volume":"89","author":"Rask","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.neurot.2025.e00576_bib52","doi-asserted-by":"crossref","first-page":"5792","DOI":"10.1158\/0008-5472.CAN-05-1021","article-title":"Kinase-inactive glycogen synthase kinase 3beta promotes Wnt signaling and mammary tumorigenesis","volume":"65","author":"Farago","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.neurot.2025.e00576_bib53","doi-asserted-by":"crossref","first-page":"7756","DOI":"10.1158\/0008-5472.CAN-06-4665","article-title":"The role of glycogen synthase kinase 3beta in the transformation of epidermal cells","volume":"67","author":"Ma","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.neurot.2025.e00576_bib54","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1016\/j.ccell.2023.09.001","article-title":"TIM-3 blockade in diffuse intrinsic pontine glioma models promotes tumor regression and antitumor immune memory","volume":"41","author":"Ausejo-Mauleon","year":"2023","journal-title":"Cancer Cell"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747925000546?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747925000546?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T00:11:02Z","timestamp":1762560662000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747925000546"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":56,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S1878747925000546"],"URL":"https:\/\/doi.org\/10.1016\/j.neurot.2025.e00576","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"VP3.15, a dual GSK-3\u03b2\/PDE7 inhibitor, reduces glioblastoma tumor growth though changes in the tumor microenvironment in a PTEN wild-type context","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurot.2025.e00576","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of American Society for Experimental NeuroTherapeutics.","name":"copyright","label":"Copyright"}],"article-number":"e00576"}}